Role of IRF4 in IFN-stimulated gene induction and maintenance of kaposi sarcoma-Associated herpesvirus latency in primary effusion lymphoma cells

Journal of Immunology

Volumn 191, Issue 3, 2013, Pages 1476-1485

  Forero, Adriana ^a,b   Moore, Patrick S ^a,b   Sarkar, Saumendra N ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIG5 PROTEIN; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 4; ISG60 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; EPITHELIUM CELL; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; LYMPHOMA CELL; NONHUMAN; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; TRANSCRIPTION INITIATION; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION;

CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL LINE, TRANSFORMED; ENZYME ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEK293 CELLS; HERPESVIRUS 8, HUMAN; HUMANS; INTERFERON REGULATORY FACTORS; INTERFERON TYPE I; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOMA; MUTATION; NF-KAPPA B; PROTEINS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; VIRUS LATENCY; VIRUS REPLICATION;

EID: 84880677100     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202514     Document Type: Article

References (66)

1. Tamura, T., H. Yanai, D. Savitsky, and T. Taniguchi. 2008. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26: 535-584.
2. Gabriele, L., and K. Ozato. 2007. The role of the interferon regulatory factor (IRF) family in dendritic cell development and function. Cytokine Growth Factor Rev. 18: 503-510.
3. Chang, P. C., L. D. Fitzgerald, A. Van Geelen, Y. Izumiya, T. J. Ellison, D. H. Wang, D. K. Ann, P. A. Luciw, and H. J. Kung. 2009. Kruppel-Associated box domain-Associated protein-1 as a latency regulator for Kaposi's sarcomaassociated herpesvirus and its modulation by the viral protein kinase. Cancer Res. 69: 5681-5689.
4. Meraro, D., M. Gleit-Kielmanowicz, H. Hauser, and B. Z. Levi. 2002. IFNstimulated gene 15 is synergistically activated through interactions between the myelocyte/lymphocyte-specific transcription factors, PU.1, IFN regulatory factor-8/IFN consensus sequence binding protein, and IFN regulatory factor-4: characterization of a new subtype of IFN-stimulated response element. J. Immunol. 168: 6224-6231.
5. Kanno, Y., B. Z. Levi, T. Tamura, and K. Ozato. 2005. Immune cell-specific amplification of interferon signaling by the IRF-4/8-PU.1 complex. J. Interferon Cytokine Res. 25: 770-779.
6. Yamagata, T., J. Nishida, S. Tanaka, R. Sakai, K. Mitani, M. Yoshida, T. Taniguchi, Y. Yazaki, and H. Hirai. 1996. A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol. Cell. Biol. 16: 1283-1294.
7. Rosenbauer, F., J. F. Waring, J. Foerster, M. Wietstruk, D. Philipp, and I. Horak. 1999. Interferon consensus sequence binding protein and interferon regulatory factor-4/Pip form a complex that represses the expression of the interferonstimulated gene-15 in macrophages. Blood 94: 4274-4281.
8. Iida, S., P. H. Rao, M. Butler, P. Corradini, M. Boccadoro, B. Klein, R. S. Chaganti, and R. Dalla-Favera. 1997. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat. Genet. 17: 226-230.
9. Shaffer, A. L., N. C. T. Emre, L. Lamy, V. N. Ngo, G. Wright, W. Xiao, J. Powell, S. Dave, X. Yu, H. Zhao, et al. 2008. IRF4 addiction in multiple myeloma. Nature 454: 226-231.
10. Carbone, A., A. Gloghini, L. M. Larocca, D. Capello, F. Pierconti, V. Canzonieri, U. Tirelli, R. Dalla-Favera, and G. Gaidano. 2001. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood 97: 744-751.
11. Mamane, Y., N. Grandvaux, E. Hernandez, S. Sharma, S. A. Innocente, J. M. Lee, N. Azimi, R. Lin, and J. Hiscott. 2002. Repression of IRF-4 target genes in human T cell leukemia virus-1 infection. Oncogene 21: 6751-6765.
12. Sharma, S., N. Grandvaux, Y. Mamane, P. Genin, N. Azimi, T. Waldmann, and J. Hiscott. 2002. Regulation of IFN regulatory factor 4 expression in human T cell leukemia virus-I-transformed T cells. J. Immunol. 169: 3120-3130.
13. Mamane, Y., S. Sharma, N. Grandvaux, E. Hernandez, and J. Hiscott. 2002. IRF-4 activities in HTLV-I-induced T cell leukemogenesis. J. Interferon Cytokine Res. 22: 135-143.
14. Xu, D., L. Zhao, L. Del Valle, J. Miklossy, and L. Zhang. 2008. Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes. J. Virol. 82: 6251-6258.
15. Izumiya, Y., C. Izumiya, D. Hsia, T. J. Ellison, P. A. Luciw, and H. J. Kung. 2009. NF-kappaB serves as a cellular sensor of Kaposi's sarcoma-Associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBPJkappa coactivator. J. Virol. 83: 4435-4446.
16. Jaffe, E. S. 1996. Primary body cavity-based AIDS-related lymphomas. Evolution of a new disease entity. Am. J. Clin. Pathol. 105: 141-143.
17. Dotti, G., R. Fiocchi, T. Motta, B. Facchinetti, B. Chiodini, G. M. Borleri, G. Gavazzeni, T. Barbui, and A. Rambaldi. 1999. Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8. Leukemia 13: 664-670.
18. Carbone, A., A. Gloghini, M. R. Cozzi, D. Capello, A. Steffan, P. Monini, L. De Marco, and G. Gaidano. 2000. Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis. Br. J. Haematol. 111: 247-257.
19. Cesarman, E., P. S. Moore, P. H. Rao, G. Inghirami, D. M. Knowles, and Y. Chang. 1995. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-Associated herpesvirus-like (KSHV) DNA sequences. Blood 86: 2708-2714.
20. Sarid, R., O. Flore, R. A. Bohenzky, Y. Chang, and P. S. Moore. 1998. Transcription mapping of the Kaposi's sarcoma-Associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J. Virol. 72: 1005-1012.
21. Dresang, L. R., J. R. Teuton, H. Feng, J. M. Jacobs, D. G. Camp, II, S. O. Purvine, M. A. Gritsenko, Z. Li, R. D. Smith, B. Sugden, et al. 2011. Coupled transcriptome and proteome analysis of human lymphotropic tumor viruses: insights on the detection and discovery of viral genes. BMC Genomics 12: 625.
22. Zhong, W., H. Wang, B. Herndier, and D. Ganem. 1996. Restricted expression of Kaposi sarcoma-Associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc. Natl. Acad. Sci. USA 93: 6641-6646.
23. Wen, K. W., and B. Damania. 2010. Kaposi sarcoma-Associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett. 289: 140-150.
24. Lee, H. R., K. Brulois, L. Wong, and J. U. Jung. 2012. Modulation of immune system by Kaposi's sarcoma-Associated herpesvirus: lessons from viral evasion strategies. Front Microbiol. 3: 44.
25. Thome, M., P. Schneider, K. Hofmann, H. Fickenscher, E. Meinl, F. Neipel, C. Mattmann, K. Burns, J. L. Bodmer, M. Schrö ter, et al. 1997. Viral FLICEinhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386: 517-521.
26. Rossetto, C. C., and G. S. Pari. 2011. Kaposi's sarcoma-Associated herpesvirus noncoding polyadenylated nuclear RNA interacts with virus-And host cellencoded proteins and suppresses expression of genes involved in immune modulation. J. Virol. 85: 13290-13297.
27. Chaudhary, P. M., A. Jasmin, M. T. Eby, and L. Hood. 1999. Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins. Oncogene 18: 5738-5746.
28. Liu, L., M. T. Eby, N. Rathore, S. K. Sinha, A. Kumar, and P. M. Chaudhary. 2002. The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex. J. Biol. Chem. 277: 13745-13751.
29. Sun, Q., S. Zachariah, and P. M. Chaudhary. 2003. The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation. J. Biol. Chem. 278: 52437-52445.
30. Chugh, P., H. Matta, S. Schamus, S. Zachariah, A. Kumar, J. A. Richardson, A. L. Smith, and P. M. Chaudhary. 2005. Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice. Proc. Natl. Acad. Sci. USA 102: 12885-12890.
31. Guasparri, I., S. A. Keller, and E. Cesarman. 2004. KSHV vFLIP is essential for the survival of infected lymphoma cells. J. Exp. Med. 199: 993-1003.
32. Rossetto, C. C., N. K. Susilarini, and G. S. Pari. 2011. Interaction of Kaposi's sarcoma-Associated herpesvirus ORF59 with oriLyt is dependent on binding with K-Rta. J. Virol. 85: 3833-3841.
33. Grossmann, C., and D. Ganem. 2008. Effects of NFkappaB activation on KSHV latency and lytic reactivation are complex and context-dependent. Virology 375: 94-102.
34. Sarkar, S. N., K. L. Peters, C. P. Elco, S. Sakamoto, S. Pal, and G. C. Sen. 2004. Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat. Struct. Mol. Biol. 11: 1060-1067.
35. Corte-Real, S., C. Collins, F. Aires da Silva, J. P. Simas, C. F. Barbas, III, Y. Chang, P. Moore, and J. Goncalves. 2005. Intrabodies targeting the Kaposi sarcoma-Associated herpesvirus latency antigen inhibit viral persistence in lymphoma cells. Blood 106: 3797-3802.
36. Toptan, T., L. Fonseca, H. J. Kwun, Y. Chang, and P. S. Moore. 2013. Complex alternative cytoplasmic protein isoforms of the Kaposi's sarcoma-Associated herpesvirus latency-Associated nuclear antigen 1 generated through noncanonical translation initiation. J. Virol. 87: 2744-2755.
37. Seaman, W. T., D. Ye, R. X. Wang, E. E. Hale, M. Weisse, and E. B. Quinlivan. 1999. Gene expression from the ORF50/K8 region of Kaposi's sarcomaassociated herpesvirus. Virology 263: 436-449.
38. Kwun, H. J., S. R. da Silva, I. M. Shah, N. Blake, P. S. Moore, and Y. Chang. 2007. Kaposi's sarcoma-Associated herpesvirus latency-Associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing. J. Virol. 81: 8225-8235.
39. Rivas, C., A. E. Thlick, C. Parravicini, P. S. Moore, and Y. Chang. 2001. Kaposi's sarcoma-Associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J. Virol. 75: 429-438.
40. Shair, K. H., C. I. Schnegg, and N. Raab-Traub. 2008. EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration. Cancer Res. 68: 6997-7005.
41. Lukac, D. M., R. Renne, J. R. Kirshner, and D. Ganem. 1998. Reactivation of Kaposi's sarcoma-Associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252: 304-312.
42. Zhu, J., K. Smith, P. N. Hsieh, Y. K. Mburu, S. Chattopadhyay, G. C. Sen, and S. N. Sarkar. 2010. High-throughput screening for TLR3-IFN regulatory factor 3 signaling pathway modulators identifies several antipsychotic drugs as TLR inhibitors. J. Immunol. 184: 5768-5776.
43. Meerbrey, K. L., G. Hu, J. D. Kessler, K. Roarty, M. Z. Li, J. E. Fang, J. I. Herschkowitz, A. E. Burrows, A. Ciccia, T. Sun, et al. 2011. The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc. Natl. Acad. Sci. USA 108: 3665-3670.
44. Arguello, M., M. Sgarbanti, E. Hernandez, Y. Mamane, S. Sharma, M. Servant, R. Lin, and J. Hiscott. 2003. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines. Oncogene 22: 964-973.
45. Honda, K., and T. Taniguchi. 2006. IRFs: master regulators of signalling by Tolllike receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6: 644-658.
46. de Veer, M. J., H. Sim, J. C. Whisstock, R. J. Devenish, and S. J. Ralph. 1998. IFI60/ISG60/IFIT4, a new member of the human IFI54/IFIT2 family of interferon-stimulated genes. Genomics 54: 267-277.
47. Lou, Y. J., X. R. Pan, P. M. Jia, D. Li, S. Xiao, Z. L. Zhang, S. J. Chen, Z. Chen, and J. H. Tong. 2009. IRF-9/STAT2 [corrected] functional interaction drives retinoic acid-induced gene G expression independently of STAT1. Cancer Res. 69: 3673-3680.
48. Renne, R., W. Zhong, B. Herndier, M. McGrath, N. Abbey, D. Kedes, and D. Ganem. 1996. Lytic growth of Kaposi's sarcoma-Associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 2: 342-346.
49. Boshoff, C., S. J. Gao, L. E. Healy, S. Matthews, A. J. Thomas, L. Coignet, R. A. Warnke, J. A. Strauchen, E. Matutes, O. W. Kamel, et al. 1998. Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood 91: 1671-1679.
50. Severa, M., E. M. Coccia, and K. A. Fitzgerald. 2006. Toll-like receptordependent and -independent viperin gene expression and counter-regulation by PRDI-binding factor-1/BLIMP1. J. Biol. Chem. 281: 26188-26195.
51. Cloutier, N., N. Grandvaux, and L. Flamand. 2007. Synergistic activation of interferon-beta gene transcription by the viral FLICE inhibitory protein of Kaposi's sarcoma-Associated herpesvirus and type I IFN activators. Eur. J. Immunol. 37: 2772-2778.
52. Cloutier, N., and L. Flamand. 2010. Kaposi sarcoma-Associated herpesvirus latency-Associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoter. J. Biol. Chem. 285: 7208-7221.
53. Bi, X., L. Yang, M. E. Mancl, and B. J. Barnes. 2011. Modulation of interferon regulatory factor 5 activities by the Kaposi sarcoma-Associated herpesvirusencoded viral interferon regulatory factor 3 contributes to immune evasion and lytic induction. J. Interferon Cytokine Res. 31: 373-382.
54. Joo, C. H., Y. C. Shin, M. Gack, L. Wu, D. Levy, and J. U. Jung. 2007. Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-Associated herpesvirus viral IRF homolog vIRF3. J. Virol. 81: 8282-8292.
55. Lubyova, B., and P. M. Pitha. 2000. Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors. J. Virol. 74: 8194-8201.
56. Biswas, P. S., S. Gupta, E. Chang, L. Song, R. A. Stirzaker, J. K. Liao, G. Bhagat, and A. B. Pernis. 2010. Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. J. Clin. Invest. 120: 3280-3295.
57. Sakakibara, S., C. A. Pise-Masison, J. N. Brady, and G. Tosato. 2009. Gene regulation and functional alterations induced by Kaposi's sarcoma-Associated herpesvirus-encoded ORFK13/vFLIP in endothelial cells. J. Virol. 83: 2140-2153.
58. Guito, J., and D. M. Lukac. 2012. KSHV Rta promoter specification and viral reactivation. Front. Microbiol. 3: 30.
59. Zhang, J., J. Wang, C. Wood, D. Xu, and L. Zhang. 2005. Kaposi's sarcomaassociated herpesvirus/human herpesvirus 8 replication and transcription activator regulates viral and cellular genes via interferon-stimulated response elements. J. Virol. 79: 5640-5652.
60. Chang, P. C., Y. Izumiya, C. Y. Wu, L. D. Fitzgerald, M. Campbell, T. J. Ellison, K. S. Lam, P. A. Luciw, and H. J. Kung. 2010. Kaposi's sarcoma-Associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific. J. Biol. Chem. 285: 5266-5273.
61. Pfeffer, L. M., J. G. Kim, S. R. Pfeffer, D. J. Carrigan, D. P. Baker, L. Wei, and R. Homayouni. 2004. Role of nuclear factor-kappaB in the antiviral action of interferon and interferon-regulated gene expression. J. Biol. Chem. 279: 31304-31311.
62. Alkharsah, K. R., V. V. Singh, R. Bosco, S. Santag, A. Grundhoff, A. Konrad, M. Stürzl, D. Wirth, O. Dittrich-Breiholz, M. Kracht, and T. F. Schulz. 2011. Deletion of Kaposi's sarcoma-Associated herpesvirus FLICE inhibitory protein, vFLIP, from the viral genome compromises the activation of STAT1-responsive cellular genes and spindle cell formation in endothelial cells. J. Virol. 85: 10375-10388.
63. Wang, J., J. Zhang, L. Zhang, W. Harrington, Jr., J. T. West, and C. Wood. 2005. Modulation of human herpesvirus 8/Kaposi's sarcoma-Associated herpesvirus replication and transcription activator transactivation by interferon regulatory factor 7. J. Virol. 79: 2420-2431.
64. de Oliveira, D. E., G. Ballon, and E. Cesarman. 2010. NF-kappaB signaling modulation by EBV and KSHV. Trends Microbiol. 18: 248-257.
65. Ye, F. C., F. C. Zhou, J. P. Xie, T. Kang, W. Greene, K. Kuhne, X. F. Lei, Q. H. Li, and S. J. Gao. 2008. Kaposi's sarcoma-Associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency. J. Virol. 82: 4235-4249.
66. Brown, H. J., M. J. Song, H. Deng, T. T. Wu, G. Cheng, and R. Sun. 2003. NF-kappaB inhibits gammaherpesvirus lytic replication. J. Virol. 77: 8532-8540.